Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001588059-19-000004
Filing Date
2019-01-02
Accepted
2019-01-02 14:10:48
Documents
1
Effectiveness Date
2019-01-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12537
  Complete submission text file 0001588059-19-000004.txt   13684
Mailing Address 1030 MASSACHUSETTS AVENUE, SUITE 410 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE, SUITE 410 CAMBRIDGE MA 02138 857-285-4300
Navitor Pharmaceuticals, Inc. (Filer) CIK: 0001588059 (see all company filings)

EIN.: 270637654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-329411 | Film No.: 19501066